North America Blood Glucose Monitoring System Market

North America Blood Glucose Monitoring System Market is expected to reach USD XX Billion by 2026 from USD XX Billion in 2016 at a CAGR of XX% (Detailed analysis of the market CAGR is provided in the report). Blood glucose monitoring, in general, is a way of testing glucose concentration within blood, which in other words is known as glycemia. A blood glucose test is normally performed by piercing on the skin of the finger to draw blood which is applied over a chemically active test-strip. Manufacturers use different technologies for measurement, with most systems measuring electrical characteristic for determining glucose level present in the blood. A blood glucose meter is required for monitoring the glucose level, which is a small and portable machine. It is also used for measuring the type of glucose and its presence within the blood and has recently become quite cost efficient and better availability as well. People having diabetes often use a blood glucose meter to receive real-time information about their health and also help them manage their condition accordingly.

North America Blood Glucose Monitoring System market

Blood Glucose Monitoring System market for North America has been divided on the basis of product, testing type, patient care setting, application, and geography. Based on the product, the market has been segmented into self-monitoring and continuous monitoring systems. The self-monitoring systems accounted for the largest share with continuous monitoring growing at a high CAGR as compared to other segments. Rising incidences of patients getting directly involved with their medical treatment along with the easy availability of real-time data have resulted in more number of people opting for self-monitoring devices. By testing type, the market for blood glucose monitoring system has been divided into fingertip and alternate site testing with fingertip holding a larger market share. The traditional way of ejecting blood has been through fingertips resulting in its dominance over other segments. The growing advances in the healthcare sector have resulted in people getting more aware of their body. This trend has further led to the high demand for minimally invasive surgeries or treatments where people still prefer certain traditional medications leading to a higher market share of the fingertip. The market on the basis of patient care setting has been further segmented into homecare and hospitals. Homecare has come across as a dominant segment followed by hospitals. Cost efficiency, portability and growing awareness regarding continuous monitoring of diabetes’s have formed some important reasons that have driven overall growth. Diabetes 2 will hold the largest market share in the application segment.

North America has been focused on evolutions in the healthcare sector with pharmaceutical companies opting for cost-effective solutions that may help patients suffering from diabetes. The US and Canada have both been actively working on delivering cost-effective solutions for diabetes that is expected to dominate world health care in the next 20 years.